You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Vaginal Atrophy: The 21st Century Health Issue Affecting Quality of Life: Conclusion



all cause ovarian dysfunction and lead to vaginal atrophy. For example, patients with breast cancer treated with an aromatase inhibitor have been found to experience significant vaginal dryness and painful coitus.[11]Women are living longer, healthier, productive lives, and are now expected to live about one third of their lives after menopause. Vaginal atrophy and related symptoms associated with natural or induced menopause, cancer treatment, lactation, medications, or chronic conditions warrant prompt identification, correct diagnosis, and optimal treatment. A variety of safe, effective treatment options are available. Careful assessment of the needs of individual needs and preference may facilitate successful treatment outcome. Sexuality can be enhanced, urologic functioning significantly improved, and quality of life positively affected when vaginal atrophy is recognized and treated.

Supported by an independent educational grant from NovoNordisk

  • Print